Analytical Biosciences Committee

Committee

Daniel’s research is in the area of bioprocess analysis. The area is fundamentally linked to the speed and capabilities of the analytical techniques used. The rise of 'omics' (genomics, proteomics, transcriptomics and metabolomics) has lead to significant efforts in the area of analytical instrumentation to match these needs. This offers exciting possibilities to those engaged in the analysis of processes involving biological molecules at every scale. Daniel carried out pioneering studies into the use of biosensors to monitor and control the production of biopharmaceuticals.

Alastair Dent is Managing Director of Fleet Bioprocessing Ltd., a service company providing custom immunoassay development, and which develops and manufactures protein conjugates and other reagents for diagnostic and biopharmaceutical applications. Bioanalytical interests include the characterisation of proteins and protein conjugates, and the use of immunoassays to detect molecules of biochemical interest.

Members

Anna Hills joined the National Physical Laboratory in 2006 to lead the Biopharmaceutical analysis technical area in the Biotechnology Group. Anna has ten years experience in biological molecule characterisation, working in industry and academia. Particular interests include glycoprotein analysis and mammalian cell technology. Anna has taken the lead in formulation of research proposals to develop and extend NPL knowledge by applying specialist knowledge to new projects in areas relevant to the Government Technology Strategy, and worked with groups across NPL to form multi-disciplinary approaches to biophysical characterisation.

Mark is Head of Bioanalysis at Syngenta’s Jealott’s Hill International Research Centre in Berkshire. He has over 20 years’ experience in industry and has worked in agrochemicals, agricultural biotechnology, environmental sciences, fine chemicals manufacturing and pharmaceuticals.

In this section

Tools

Email this to a friend